U.S. construction spending declined 1.7% in January 2008, as private builders continued to pull-back amid the housing slump, the U.S. Commerce Department announced Monday.
Economists surveyed by Bloomberg News had expected construction spending to decline 0.7% in January 2008. Construction spending is down 3.3% on a year-over-year basis.
Meanwhile, the December 2007 construction spending statistic was revised downward, to a 1.3% decline, from the earlier announced 1.1% decline, the Commerce Department said.
In January 2008, private residential construction declined 2.9%, public construction dropped 0.2%
Spending on private construction totaled a seasonally-adjusted annual rate of $827.4 billion, 2.2% (plus/minus 1.1%) below the revised December 2007 estimate of $845.7 billion. The estimated seasonally-adjusted annual rate of public construction spending was $294.1 billion, 0.2% (plus/minus 0.8%) below the revised December 2007 estimate of $294.7 billion.
Economic Analysis: Another negative data point for the U.S. economy. The telling stat: a 3.3% year-over-year decline in construction spending. Further, the January 2008 private construction statistic contained declines in almost every category, which suggests that building continues to contract across-the-board. Further, the 2.9% decline in private residential construction indicates that builders continue to retreat from the housing sector, a statistic that's consistent with other recent data indicating slowing home sales and rising inventories.
Last updated: February 13, 2012: 01:27 PM
Hot Stocks
DailyFinance Headlines
- 3 Keys to a Great Balance Transfer Card (and 1 Card That Offers Them)
- Is It Already 'The End' for E-Book Readers?
- Retail Stocks Are for Suckers: Why Their Rally Won't Last
- Suddenly, Amazon Doesn't Love Its Moms Anymore
- How State Taxes Put a Bigger Pinch on the Poor
Benzinga Headlines
- Airlines the Latest to Suffer Euro Crisis Blues
- Internet-Hungry Consumers Force Vodafone to Consider a C&W Offer
- Seven Japanese Stocks Up More Than 10% Year to Date
- Does the 2012 Election Really Matter for the Economy?
- Michigan Consumer Sentiment Index Drops
TheFlyOnTheWall.com Headlines
- European Commission approves acquisition of Motorola Mobility by Google
- Blue Coat Systems shareholders approve merger with Thoma Bravo
- Google confirms services blocked in Iran, Bloomberg reports
- NYSE market internals summary
- Google's proposed acquisition of Motorola Mobility cleared by EU, Bloomberg says
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- 3 Keys to a Great Balance Transfer Card (and 1 Card That Offers Them)
- Is It Already 'The End' for E-Book Readers?
- Retail Stocks Are for Suckers: Why Their Rally Won't Last
- Suddenly, Amazon Doesn't Love Its Moms Anymore
- How State Taxes Put a Bigger Pinch on the Poor
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
5-Hour Energy: A Success Equal Parts Caffeine, Chemistry and…
How State Taxes Put a Bigger Pinch on the Poor

